SEC Form 4/A · accession 0001654954-18-013409
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Janet Dillione
Director
Period of report
Feb 16, 2018
Accepted (ET)
Nov 30, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 16, 2018 | A | 14,000 | — | A | 106,052 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $0.57 | Feb 16, 2018 | A | 40,000 | A | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 13,392 | 13,392 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 15,625 | 15,625 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 20,833 | 20,833 | D |
| Stock Option (Right to Buy Common Stock)F4 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F5 | $3.03 | holding | — | — | — | — | Aug 11, 2015 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to Buy Common Stock)F6 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 3,831 | 3,831 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
| Phantom StockF3 | — | holding | — | — | — | — | — | Common Stock | 15,306 | 15,306 | D |
| Restricted Stock UnitsF7 | — | holding | — | — | — | — | — | Common Stock | 15,357 | 15,357 | D |
Explanation of responses
- F1These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported.
- F2These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F4These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F5These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F6These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F7These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.